|
|
Volumn 152, Issue 20, 2010, Pages 43-44
|
|
Diabetes therapy - Novel drugs to come (DPP-4 inhibitors, GLP-1 agonists, SGLT-2 inhibitors);DPP-4-inhibitoren, GLP-1-agonisten, SGLT-2-inhibitoren: Neue ansätze in der therapie des typ-2-diabetes
|
|
Author keywords
Antidiabetic therapy; DPP 4 inhibitors; GLP 1 agonists; SGLT 2 inhibitors; Type 2 diabetes
|
|
Indexed keywords
DAPAGLIFLOZIN;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
EXENDIN 4;
GLITAZONE DERIVATIVE;
GLUCAGON LIKE PEPTIDE 1;
HEMOGLOBIN A1C;
INSULIN;
METFORMIN;
SAXAGLIPTIN;
SERGLIFLOZIN ETABONATE;
SITAGLIPTIN;
SODIUM GLUCOSE COTRANSPORTER 2;
SULFONYLUREA;
VILDAGLIPTIN;
CLINICAL TRIAL;
COMPETITIVE INHIBITION;
CONFERENCE PAPER;
HUMAN;
HYPOGLYCEMIA;
INSULIN RELEASE;
INSULIN TREATMENT;
MONOTHERAPY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
|
|
EID: 77953145811
PISSN: 14383276
EISSN: None
Source Type: Journal
DOI: 10.1007/bf03366604 Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (0)
|
